Pharma Marketletter
Global prescription pharmaceutical,
generic and biotechnology business news. Your concise daily/weekly
briefing on industry events.
Since 1974, Marketletter has become synonymous with delivering high-standard
information, together with accurate and unbiased reporting. Thousands of senior
executives in the pharmaceutical, generic and biotech industries, and the people
supporting them, have found Pharma Marketletter a necessary read to keep them
amongst the first with the news and, importantly, at the right price.
Save yourself time and effort in sourcing the news you need to know, analysed and verified information from our longstanding international network of corporate, industry and regulatory contacts.
- Company news. Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences, R&D trends, M&A activity, sales performance, stock market analyses and personnel appointments.
- Product news. Drug submissions, approvals and rejections, licensing arrangements, clinical trial developments and results, product development and new product introductions.
- European, USA and world news. Regulatory developments, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details and write-ups.
Get authoritative, independent, unbiased news analysis delivered to you in either print or pdf weekly, daily online straight to your screen with e-mail alerts and full access to Marketletter’s searchable archive from 1991.
Make sure you benefit from always having the latest information to hand – use the subscribe link on the left to subscribe to Marketletter now.